EFFICIENT COMPREHENSIVE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION AND POSTCOVIDAL SYNDROME IN ELDERLY PATIENTS
Authors:
- 1 January 2021
- journal article
- research article
- Published by ALUNA in Wiadomości Lekarskie
- Vol. 75 (6) , 1486-1491
Abstract
The aim: The purpose of the study is to increase the efficacy of сomprehensive treatment in elderly patients with COPD , who have suffered of coronavirus disease-COVID-19 in the last 3-6 months, by using nebulizer therapy with N-acetylcysteine and 3% hypertonic sodium chloride solution (Flu-Acyl broncho) and the drug glycine, to correct psychosomatic disorders. Materials and methods: Under our supervision there were 60 elderly patients with COPD gr D, who underwent Covid 19 in the last 3-6 months, were under observation. The average age was 66.3±2.1 years. Рatients of the main and control groups were prescribed complex basic therapy. However, mucolytic therapy was administered to patients in the main group using combined drug - N-acetylcysteine and 3% hypertonic sodium chloride solution through a 5.0 №10 nebulizer. For the treatment of astheno-neurotic disorders of postcovidal syndrome was prescribed glycine 100 mg 2 times a day for 10 days. Subsequently, Flu-Acyl broncho through a nebulizer at 5.0 No.10, and glycised was used in courses once a day for 10 days per month. Patients in the control group were prescribed acetylcysteine 200 mg 3 times a day N10. Results: The results of observation for 6 months showed that in patients of the main group, recurrence of the disease was not observed. whereas in patients of the control group in 6 patients (20%). Conclusions: Comprehensive treatment of elderly patients with comorbid pathology - COPD group D and postcovidal syndrome, with the additional use of nebulizer delivery of the combined drug - N-acetylcysteine and 3% hypertonic sodium chloride solution in combination with the sedative drug glycine, promotes improving the quality of life in patients, reducing the duration of treatment, prevents recurrence and progression of COPD.Keywords
This publication has 10 references indexed in Scilit:
- Застосування інгаляційних засобів для зниження частоти загострень хронічного бронхітуUkrainian Medical Journal, 2021
- Treatment of Patients with Mental Illness Amid A Global COVID-19 Pandemic2021
- PATIENT-CENTERED COMPREHENSIVE APPROACH IN COMBINED PATHOLOGY MANAGEMENT: ASTHMA / COPD CROSSАктуальні проблеми сучасної медицини: Вісник Української медичної стоматологічної академії, 2021
- THE INFLUENCE OF RATIONAL COMBINATION THERAPY ON THE QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASEThe Medical and Ecological Problems, 2020
- EVALUATION OF HEALTHY LIFESTYLING LEVEL IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASEWorld of Medicine and Biology, 2020
- Clinical-Functional Characteristics of Patients with Chronic Obstructive Pulmonary Disease Depending on the Parameters of the Red Branch of Blood and the Content of Soluble Transferrin ReceptorsLviv clinical bulletin, 2018
- The Effectiveness of Patient-Oriented Correction of Adherence to Treatment in Patients with Arterial Hypertension and Comorbid Chronic Obstructive Pulmonary DiseaseLviv clinical bulletin, 2018
- Nebulized therapy: practical aspectsAsthma and allergy, 2018
- Assessment of the quality of life in patients with chronic obstructive pulmonary disease according to concomitant disorders of psycho-emotional sphereScienceRise: Medical Science, 2017
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary Updated 2003COPD: Journal of Chronic Obstructive Pulmonary Disease, 2004